Table 1.

Characteristics of the study population

Clinical features	HCC group	Control group	P value
Men	23	25
Women	10	14
Age, years	57 ± 9	51 ± 12	0.17
Types of disease
Cancer	33
Cirrhosis		6
Hepatitis		29
Healthy		4
Stage of cancer
I	6
II	8
III	12
IV	7
ALT, U/L	38.1 ± 21.1	31.8 ± 19.4	0.37
AST, U/L	81.1 ± 83.3	30.2 ± 14.3	0.04
Total bilirubin, mg/dL	34.1 ± 31.3	13.9 ± 5.7	0.02

HCC: hepatocellular carcinoma; ALT: alanine aminotransferase; AST: aspartate aminotransferase.